pyridostigmine bromide has been researched along with Intellectual Disability in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, S; Crenshaw, M; DiBartolomeo, M; Geller, T; Iyadurai, S; Wyrebek, R | 1 |
| Dörner, G; Hecht, K; Hinz, G; Poppe, I; Poppei, M; Tönjes, R; Tsamaloukas, A | 1 |
2 other study(ies) available for pyridostigmine bromide and Intellectual Disability
| Article | Year |
|---|---|
Hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmine.
Topics: Acetylcholinesterase; Apnea; Channelopathies; DNA-Binding Proteins; Epilepsy; Humans; Infant; Intellectual Disability; Pyridostigmine Bromide; Transcription Factors | 2022 |
Pyridostigmine administration in newborn rats prevents permanent mental ill-effects produced by maternal deprivation.
Topics: Acetylcholinesterase; Animals; Animals, Newborn; Humans; Intellectual Disability; Learning; Maternal Deprivation; Pyridostigmine Bromide; Rats | 1981 |